Investor Name | Invest Money | Lead Investor | Propotion |
---|
Announced Date | Round | Money Raised | Investors | |
---|---|---|---|---|
Apr 2, 2019 | Series D | $ 40M | Medicxi | Detail |
Mar 22, 2021 | Series Unknown | $ 80M | Adage Capital Management,Advent Life Sciences,etc. | Detail |
Sep 29, 2016 | Series Unknown | $ 8M | Detail | |
Sep 1, 2010 | Series A | $ 1.40M | Detail | |
Dec 26, 2012 | Series Unknown | $ 3.22M | Detail | |
Aug 15, 2014 | Series Unknown | $ 4M | Detail | |
Mar 5, 2015 | Series B | $ 21M | Advent Life Sciences,Alexandria Venture,etc. | Detail |
Nov 3, 2021 | Post-IPO Equity | 0 | Ysios Capital | Detail |
Aug 26, 2011 | Series A | $ 3M | Detail | |
Jun 25, 2020 | Series D | 0 | Myelin VC | Detail |
Dec 21, 2017 | Series C | $ 30M | Advent Life Sciences,Alexandria Venture Investments,etc. | Detail |
Jul 9, 2020 | Series Unknown | $ 10M | Detail | |
Jan 8, 2014 | Debt Financing | $ 1.33M | Detail | |
Oct 29, 2021 | IPO | $ 75.60M | Detail |